Dr. Lataillade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Perryridge Rd
Greenwich, CT 06830Phone+1 203-863-3685Fax+1 203-863-4738
Education & Training
- Yale-New Haven Medical CenterFellowship, Infectious Disease, 2004 - 2007
- Crozer-Chester Medical CenterResidency, Internal Medicine, 2001 - 2004
- Rowan University School of Osteopathic MedicineClass of 2001
Certifications & Licensure
- CT State License 2004 - 2025
- PA State License 2001 - 2004
Publications & Presentations
PubMed
- 79 citationsFostemsavir in Adults with Multidrug-Resistant HIV-1 InfectionMichael J. Kozal, Judith A. Aberg, Gilles Pialoux, Pedro Cahn, Melanie Thompson
The New England Journal of Medicine. 2020-03-25 - 105 citationsIn Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe, Ira B. Dicker, Hsu-Tso Ho
Antimicrobial Agents and Chemotherapy. 2012-07-01 - 52 citationsSafety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob Lalezari, Michael J. Kozal, Judith A. Aberg, Gilles Pialoux
The Lancet. HIV. 2020-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: